ConductScience.org, home

Paper1865542

A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group.

Greenman RL and 9 others. JAMA, 1991. Cited by 580 papers, by iCite.

Cite this record

ConductScience Library. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group. Papers, record 1865542. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1865542

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group.
PubMed
Journal
JAMA
PubMed
Year
1991
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
580
iCite
Relative citation ratio, by iCite
20.4
iCite
Revised in PubMed
2016-10-17
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Greenman RLR L
2Schein RMR M
3Martin MAM A
4Wenzel RPR P
5MacIntyre NRN R
6Emmanuel GG
7Chmel HH
8Kohler RBR B
9McCarthy MM
10Plouffe JJ

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, MonoclonalMajor topic
EndotoxinsMajor topic
Gram-Negative BacteriaMajor topic
Immunoglobulin MMajor topic
SepsisMajor topic
Aged
Clinical Protocols
Double-Blind Method
Female
Humans
Male
Middle Aged
Multiple Organ Failure
Prospective Studies
Shock, Septic

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in1865548Monoclonal antibodies to endotoxin. New allies against sepsis?https://conductscience.org/library/papers/1865548

Source PubMed

Download CSV of comments and corrections

Cited by121

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 580 citations.

PMIDTitleJournalYearIn PapersSource
41751298Modes of (Inter)Actions of Polyvalent Immunoglobulins: Nonclinical and Clinical Research in Severe Bacterial Infections.Biomedicines2026https://conductscience.org/library/papers/41751298PubMed
41009426Assessing Monoclonal and Polyclonal Antibodies in Sepsis and Septic Shock: A Systematic Review of Efficacy and Safety.Int J Mol Sci2025https://conductscience.org/library/papers/41009426PubMed
40904815Circulating TNF-α levels in rheumatoid arthritis: a systematic review and meta-analysis and comparison to TNF-α levels in sepsis.Ther Adv Infect Dis2025https://conductscience.org/library/papers/40904815PubMed
38860003The effect of polyclonal and monoclonal based antibodies as promising potential therapy for treatment of sepsis: A systematic review.New Microbes New Infect2024https://conductscience.org/library/papers/38860003PubMed
38017475Positive single-center randomized trials and subsequent multicenter randomized trials in critically ill patients: a systematic review.Crit Care2023https://conductscience.org/library/papers/38017475PubMed
37432116Hit 'em Where It Hurts: Gram-Negative Bacterial Lipopolysaccharide as a Vaccine Target.Microbiol Mol Biol Rev2023https://conductscience.org/library/papers/37432116PubMed
35814227Chasing the Ghost: Hyperinflammation Does Not Cause Sepsis.Front Pharmacol2022https://conductscience.org/library/papers/35814227PubMed
33066119Structure, Function, and Therapeutic Use of IgM Antibodies.Antibodies (Basel)2020https://conductscience.org/library/papers/33066119PubMed
32936727Targeted IgMs agonize ocular targets with extended vitreal exposure.MAbs2020https://conductscience.org/library/papers/32936727PubMed
32849612Biomaterial-Driven Immunomodulation: Cell Biology-Based Strategies to Mitigate Severe Inflammation and Sepsis.Front Immunol2020https://conductscience.org/library/papers/32849612PubMed
32288619Let the Cells Speak: Neutrophils as Biologic Markers of the Inflammatory Response.Sepsis (Boston)1998https://conductscience.org/library/papers/32288619PubMed
29549641Engineering Antibodies for the Treatment of Infectious Diseases.Adv Exp Med Biol2017https://conductscience.org/library/papers/29549641PubMed
29222409Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae.Nat Commun2017https://conductscience.org/library/papers/29222409PubMed
28469079Anti-LPS antibodies protect against Klebsiella pneumoniae by empowering neutrophil-mediated clearance without neutralizing TLR4.JCI Insight2017https://conductscience.org/library/papers/28469079PubMed
28115287Microbial recognition and danger signals in sepsis and trauma.Biochim Biophys Acta Mol Basis Dis2017https://conductscience.org/library/papers/28115287PubMed
26771793Endotoxin: Back to the Future.Crit Care Med2016https://conductscience.org/library/papers/26771793PubMed
25538412Alteco endotoxin hemoadsorption in Gram-negative septic shock patients.Indian J Crit Care Med2014https://conductscience.org/library/papers/25538412PubMed
25190187Strategies to improve drug development for sepsis.Nat Rev Drug Discov2014https://conductscience.org/library/papers/25190187PubMed
24916483
The EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock): study protocol for a randomized controlled trial.
Trials2014https://conductscience.org/library/papers/24916483PubMed
24351718Towards clinical applications of anti-endotoxin antibodies; a re-appraisal of the disconnect.Toxins (Basel)2013https://conductscience.org/library/papers/24351718PubMed

See all 121 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1865542

GET https://conductscience.org/api/papers/v1/1865542/cited_by?page=2